This archive is for reference only. It may not be reflective of the current situation. If you have any queries please use the contact us link.
12/7/2001
BI appoints sales and marketing director for prescription medicines
Boehringer Ingelheim has appointed Mark Connolly as Sales and Marketing Director, Prescription Medicine with responsibility for the company’s portfolio of products across primary and secondary care.
Mark has been Marketing Director for the hospital division since 1998. He joined Boehringer Ingelheim in 1978 as a sales representative and then went on to work in sales training and business development. He spent 4 years at Boehringer’s headquarters in Ingelheim where he was responsible for implementing the business strategy in northern Europe. He came back to the UK to take up a post as Marketing Director of the Hospital Division in 1998.
Announcing his new position Mark said:
‘I am looking forward to what is going to be a very challenging role. Bringing the secondary and primary care divisions together under one management enables us to work closer together to provide a better service to our customers across all sectors.’
Notes to Editors:
Boehringer Ingelheim is one of the top 20 leading pharmaceutical companies in the world. Our headquarters are in Ingelheim, Germany and we have 140 affiliated companies worldwide. In 2000 our revenue exceeded EUR 6 billion.
We specialise in human pharmaceuticals and animal health. The human pharmaceuticals business, which accounts for 95% of sales, produces prescription medicines and consumer healthcare products for patients worldwide and chemicals and biopharmaceuticals for industrial customers.
Boehringer Ingelheim has an ongoing programme of research and development. In 2000 we invested almost EUR 1.0 billion in the research and development of new products. We have a particular interest in the fields of respiratory and cardio-vascular care, HIV and animal health and are constantly striving for innovative treatments that will improve quality of care.
For further information please contact Emma Stafford on 01344 741336.
Visit our website at www.boehringer-ingelheim.com
This news story was brought to you by Boehringer Ingelheim - the largest family-owned pharmaceutical company in the world.
What do you want to do now?
